Meet the leadership team that's helping transform spine surgery and beyond, and helping change patient lives every day.
Meet the leadership team that's helping transform spine surgery and beyond, and helping change patient lives every day.
Chairman and Chief Executive Officer
Greg Lucier serves as our Chairman and Chief Executive Officer.
Prior to this role, Mr. Lucier served as Chairman and CEO of Life Technologies Corporation for eleven years. Mr. Lucier was heading Life Technologies Corporation during the acquisition by Thermo Fisher Scientific in 2013 for $15.6 billion – one of the largest Life Sciences acquisitions to date. Before that Mr. Lucier served as President, Medical Information Technologies/GE Healthcare, overseeing the networking of medical electronic devices, digital imaging and clinical information systems with revenues of $1.8 billion. He was promoted by the GE Board to an officer of General Electric Corporation to serve as Vice President Global Services, GE Healthcare, the company’s $2 billion healthcare services business.
In addition to serving on the Board of NuVasive, he is a member of the Board of Directors for Catalent, Inc. and Invuity, Inc.
Mr. Lucier received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School.
Executive Vice President And Chief Financial Officer
Mr. Asarpota serves as our Executive Vice President and Chief Financial Officer.
His previous roles include CFO of Questcor Pharmaceuticals; work in private equity-backed healthcare companies in executive financial and operational roles; Vice President Finance at Life Technologies Corporation; and a variety of key finance operating roles at GE Healthcare. Mr. Asarpota began his career at General Electric (GE) in the GE Financial Management program, including finance roles in commercial operations, plant and manufacturing analysis, sourcing and R&D analysis. Mr. Asarpota received a bachelor’s degree from the University of Bombay in Bombay, India and an MBA from Marquette University in Milwaukee, Wisconsin.
Executive Vice President, External Affairs
Carol Cox serves as our Executive Vice President, External Affairs and is responsible for leading NuVasive’s external communications efforts, The Better Way Back and NuVasive Spine Foundation. Her prior roles include Senior Vice President, External Affairs at Sanford-Burnham Medical Research Institute; Senior Vice President of External Affairs and Corporate Communications at Life Technologies; Vice President of Investor Relations at CareFusion Corporation; and Senior Vice President for Global Corporate Communications and Investor Relations at Barr Pharmaceuticals. Ms. Cox holds a bachelor’s of arts degree in Foreign Affairs from the University of Virginia and a certificate in Investor Relations from The University of Connecticut School of Business.
Executive Vice President, Global Commercial
Skip Kiil serves as our Executive Vice President, Global Commercial, and is responsible for NuVasive’s global commercial strategies, including broad efforts to integrate the Company’s sales and service organizations.
His previous roles include Surgical Head, Europe, Middle East, Africa and Russia at Alcon, a division of Novartis Corporation; Vice President and General Manager, Medical Surgical Group based in London and Rome, at Stryker; General Manager, MedSurg Japan based in Tokyo, at Stryker; and several corporate development, sales and marketing roles at Stryker. Mr. Kiil received a Bachelor of Science in Kinesiology from California State University, Fullerton and a Masters of Business Administration from University of Michigan.
Executive Vice President, People and Culture
Pete Leddy, Ph.D., serves as our Executive Vice President, People and Culture, after serving as a member of the Company’s Board of Directors.
His prior roles include Chief Human Resources Officer at Life Technologies; several senior management positions with Dell Incorporated; Executive Vice President for Human Resources at Promus Hotel Corporation (Doubletree, Embassy Suites); and a variety of executive and human resource positions at PepsiCo. Dr. Leddy received his B.A. in Psychology from Creighton University and his M.S. and Ph.D. degrees in industrial/organizational psychology from the Illinois Institute of Technology.
Executive Vice President, Strategy, Technology and Corporate Development
Matt Link serves as our Strategy, Technology and Corporate Development leader and is responsible for NuVasive’s product and systems development, global marketing, surgeon education, clinical research and corporate development.
His prior roles at NuVasive include President, U.S. Commercial; Executive Vice President of U.S. Sales; Senior Vice President of Sales for the Company’s U.S. Eastern region; and several regional sales positions with DePuy Orthopedics and DePuy Spine. Mr. Link received a BSEd in Physical Education and Sports Medicine from the University of Virginia.
Executive Vice President, Global Process Transformation
Steve Rozow serves as our Executive Vice President, Global Process Transformation and is responsible for manufacturing, supply chain, information technology, regulatory affairs and quality assurance.
His prior roles include Vice President, Global Operations at NuVasive; Executive Vice President and Chief Operating Officer at Rauland-Borg; senior operations leadership roles including Vice President, Global Manufacturing at Zimmer. Mr. Rozow has a Bachelor of Science in Mechanical Engineering from Purdue University and a Masters of Business Administration from the University of Notre Dame.
Executive Vice President, General Counsel and Corporate Secretary
Joan Stafslien, Esq. serves as our Executive Vice President, General Counsel and Corporate Secretary.
Her previous roles include General Counsel, Corporate Secretary and Chief Compliance Officer at CareFusion; Segment General Counsel of Cardinal Health’s Clinical Technologies and Services; and Deputy General Counsel and Assistant Secretary of Alaris Medical Systems. Prior to joining Alaris, Ms. Stafslien was in private practice with Brobeck, Phleger & Harrison. Ms. Stafslien serves on the advisory board of the Chemical and Biological Engineering Department of Northwestern University and received a JD from University of Wisconsin Law School and a B.S. in Chemical Engineering from Northwestern University.
Vickie L. Capps has served as a member of our Board of Directors since June 2015. From July 2002 to December 2013, Ms. Capps served as the Chief Financial Officer of DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management. Prior to joining DJO Global, she served as the Chief Financial Officer of several other public and private companies. Earlier in her career, she served as a senior audit and accounting professional at Ernst & Young LLP. Ms. Capps is a member of the Senior Advisory Board of Consonance Capital Partners and serves on the board of its portfolio company, Enclara Pharmacia. She also serves on the board of directors and as chair of the audit committees of Otonomy, Inc. and Connecture, Inc. Ms. Capps is a California Certified Public Accountant and was recognized as CFO of the Year by the San Diego Business Journal in 2009 and 2010. She earned a bachelor’s degree in business administration/accounting from San Diego State University.
John A. DeFord, Ph.D. has served as a member of our Board since February 2018. Dr. DeFord is currently the Senior Vice President, Research and Development, Interventional Segment for Becton, Dickinson and Company, a global medical technology company. Dr. DeFord joined Becton Dickinson following its December 2017 acquisition of C.R. Bard, Inc., where he had served as Senior Vice President, Science, Technology and Clinical Affairs since June 2007. Dr. DeFord joined Bard in 2004, and served in science and technology roles of increasing responsibility since that time. Prior to joining Bard, Dr. DeFord was Managing Director of Early Stage Partners LP, a venture capital fund. Prior to joining Early Stage Partners, Dr. DeFord was President and CEO of Cook Incorporated, a privately held medical device manufacturer. Dr. DeFord is a graduate of Purdue University with a B.S. and M.S. in Electrical Engineering and a Ph.D. in Electrical/Biomedical Engineering.
Peter C. Farrell, Ph.D., AM has served as a member of our Board of Directors since January 2005. Dr. Farrell was founding Chairman and Chief Executive Officer of ResMed, Inc., a leading developer and manufacturer of medical equipment for the diagnosis and treatment of sleep-disordered breathing. Dr. Farrell has been a Director and Chairman of the Board of ResMed since its inception in June 1989. He served as Chief Executive Officer of ResMed from 1990 to 2007 and again from February 2011 until March 2013. Dr. Farrell holds bachelor’s and master’s degrees in Chemical Engineering from the University of Sydney and the Massachusetts Institute of Technology, a Ph.D. in Bioengineering from the University of Washington, Seattle, and a Doctor of Science from the University of New South Wales for research related to dialysis and renal medicine.
Robert F. Friel has served as a member of our Board of Directors since February 2016. Mr. Friel currently serves as Chairman, Chief Executive Officer and President of PerkinElmer, Inc., and has been one of the primary architects of the company’s transformation into a global technology leader focused on improving the health and safety of people and the environment. Prior to being appointed PerkinElmer’s President and Chief Executive Officer in February 2008 and Chairman in April 2009, he previously served as President and Chief Operating Officer of PerkinElmer and as Vice Chairman and President of PerkinElmer’s Life and Analytical Sciences unit. Prior to that, Mr. Friel served as Executive Vice President and Chief Financial Officer of PerkinElmer with responsibility for business development and information technology in addition to his oversight of finance functions. Previously, he held several senior management positions with AlliedSignal, Inc., now Honeywell International. Mr. Friel currently serves as a member of the board of directors of Xylem, Inc. Mr. Friel received a Bachelor of Arts degree in economics from Lafayette College and a Master of Science degree in taxation from Fairleigh Dickinson University.
Lesley H. Howe has served as a member of our Board of Directors since February 2004. Mr. Howe has more than 40 years of experience in accounting, finance, and business management within a variety of industries. During Mr. Howe’s 30-year career with KPMG Peat Marwick LLP, an international accounting and auditing firm, he was an audit partner and an area managing partner/managing partner of the Los Angeles office of KPMG. While there, Mr. Howe worked as an independent financial and business consultant, advising clients on acquisition due diligence and negotiation strategies, as well as financing strategies. Mr. Howe currently serves as a member of the board of directors of Obalon Therapeutics, Inc. Mr. Howe received a B.S. in Business Administration from the University of Arkansas.
Leslie V. Norwalk, Esq. has served as a member of our Board of Directors since May 2014. Ms. Norwalk is Strategic Counsel to Epstein Becker & Green, P.C., EBG Advisors and National Health Advisors. She also serves as an advisor to three private equity firms: Warburg Pincus, Peloton Equity, and Enhanced Equity Fund. Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services after serving as the agency’s Deputy Administrator and serving in the first Bush administration. Prior to serving the Bush Administration, she practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. Ms. Norwalk currently sits on the boards of directors of Endologix, Inc. and Providence Service Corp. (both of which are publicly-traded), as well as Abode Healthcare, HPOne, Linkwell Health, Cedar Gate, Med First, Healtheo360 and MedCircle. She is also a member of APCO Worldwide’s International Advisory Council. Ms. Norwalk earned a J.D. degree from the George Mason University School of Law and a bachelor’s degree, cum laude, in economics and international relations from Wellesley College.
Michael D. O’Halleran has served as a member of our Board of Directors since August 2016. Mr. O’Halleran currently serves as the executive chairman of Aon Benfield and senior executive vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O’Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with companies in the insurance industry. Mr. O’Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.
Donald J. Rosenberg has served as a member of our Board of Directors since February 2016. Since October 2007, Mr. Rosenberg has served as Executive Vice President, General Counsel and Corporate Secretary of QUALCOMM Incorporated, a world leader in 3G, 4G and next-generation wireless technologies. Prior to joining QUALCOMM, he served as Senior Vice President, General Counsel and Corporate Secretary of Apple Inc. Prior to that, he was Senior Vice President and General Counsel of IBM Corporation. Mr. Rosenberg has served as an adjunct professor of law at New York’s Pace University School of Law, where he taught courses in intellectual property and antitrust law. He is the immediate past National Co-Chairman of the Board of the Lawyers’ Committee for Civil Rights Under Law. He received a Bachelor of Science degree in mathematics from the State University of New York at Stony Brook and his Juris Doctor from St. John’s University School of Law.
Daniel J. Wolterman has served as a member of our Board since July 2015. Mr. Wolterman has served as the Chief Executive Officer of ColubrisMX, Inc. and X-Cath, Inc., both privately-held medical device companies, since January 2018. Mr. Wolterman previously served as President and CEO of Memorial Hermann Health System, the largest not-for-profit health system in Southeast Texas, from 2002 until his retirement from Memorial Hermann in 2016. He serves on the boards of directors of Invuity, Inc. (which is publicly-traded), Vizient, Inc. and Legacy ER + Urgent Care, Inc. Mr. Wolterman earned a B.S. degree in business administration, an M.B.A. in finance from the University of Cincinnati and a Master’s Degree in healthcare administration from Xavier University.